{"doi":"10.1002/elps.200410302","title":"Development and validation of a separation method for the diastereomers and enantiomers of aziridine‐type protease inhibitors","abstract":"<jats:title>Abstract</jats:title><jats:p>Aziridine derivatives are attracting pharmacological interest as protease inhibitors. Due to their two centers of chirality, the aziridines studied here are mixtures of two diastereomers and corresponding enantiomers. Applying cyclodextrin‐modified capillary electrophoresis resulted in a baseline separation of the four isomers. The most robust separation was obtained by means of 2 m<jats:sc>M</jats:sc> sulfated β‐cyclodextrin in 50 m<jats:sc>M</jats:sc> phosphate buffer of pH 2.5. Using this method, 0.25% of the <jats:italic>trans</jats:italic>‐diastereomers aziridine could be precisely and accurately quantified in the presence of 99.75% of the <jats:italic>cis</jats:italic>‐isomers. The corrected peak‐area ratios, migration times, and resolutions were found to be robust with respect to small variations of voltage, buffer concentrations, pH, temperature, chiral selector concentration, and different lots.</jats:p>","journal":"ELECTROPHORESIS","year":2005,"id":689963,"datarank":0.37273599746820013,"base_score":2.4849066497880004,"endowment":2.4849066497880004,"self_citation_contribution":0.37273599746820013,"citation_network_contribution":0.0,"self_endowment_contribution":0.37273599746820013,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":11,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1802507,"name":"Björn Degel","orcid":null,"position":1,"is_corresponding":false},{"id":134145,"name":"Tanja Schirmeister","orcid":null,"position":2,"is_corresponding":false},{"id":1107675,"name":"Ulrike Holzgrabe","orcid":"0000-0002-0364-7278","position":3,"is_corresponding":false},{"id":1802506,"name":"Yaser Bitar","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Development and validation of a separation method for the diastereomers and enantiomers of aziridine‐type protease inhibitors","abstract":"<jats:title>Abstract</jats:title><jats:p>Aziridine derivatives are attracting pharmacological interest as protease inhibitors. Due to their two centers of chirality, the aziridines studied here are mixtures of two diastereomers and corresponding enantiomers. Applying cyclodextrin‐modified capillary electrophoresis resulted in a baseline separation of the four isomers. The most robust separation was obtained by means of 2 m<jats:sc>M</jats:sc> sulfated β‐cyclodextrin in 50 m<jats:sc>M</jats:sc> phosphate buffer of pH 2.5. Using this method, 0.25% of the <jats:italic>trans</jats:italic>‐diastereomers aziridine could be precisely and accurately quantified in the presence of 99.75% of the <jats:italic>cis</jats:italic>‐isomers. The corrected peak‐area ratios, migration times, and resolutions were found to be robust with respect to small variations of voltage, buffer concentrations, pH, temperature, chiral selector concentration, and different lots.</jats:p>","is_dataset_classified":null,"base_score":2.4849066497880004,"endowment":2.4849066497880004,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"15912540","pmcid":null,"openalex_id":"https://openalex.org/W2073645283","authors":[],"funders":[],"total_grants":0,"fwci":2.7819,"citation_percentile":0.89409156,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":"http://onlinelibrary.wiley.com/termsAndConditions#vor","oa_locations":[{"url":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Felps.200410302","host_type":"publisher"},{"url":"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/pdf/10.1002/elps.200410302","host_type":"publisher"},{"url":"https://doi.org/10.1002/elps.200410302","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/15912540","host_type":"repository"}],"fields_of_study":["Innovative Microfluidic and Catalytic Techniques Innovation","Chemical Synthesis and Analysis","Microfluidic and Capillary Electrophoresis Applications","Aziridines","Electrophoresis, Capillary","Protease Inhibitors","Reproducibility of Results","Sensitivity and Specificity","Stereoisomerism"],"mesh_terms":["Aziridines","Protease Inhibitors","Sensitivity and Specificity","Stereoisomerism","Reproducibility of Results","Electrophoresis, Capillary"],"keywords":["Diastereomer","Aziridine","Enantiomer","Chemistry","Cyclodextrin","Capillary electrophoresis","Chromatography","Phosphate buffered saline","Chirality (physics)","Protease","Combinatorial chemistry","Stereochemistry","Organic chemistry","Ring (chemistry)","Enzyme"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-22T19:26:09.513632Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}